Key Takeaways LDN is a safe and inexpensive option for women in midlife experiencing symptoms such as inflammation, autoimmune conditions, chronic pain, fatigue, and perhaps certain mood and skin disorders
The researchers analyzed data from the TriNetX electronic health records network, comparing 2,133 patients treated with GLP-1 receptor agonists with an equal number of patients receiving metformin alone
Ozempic pen has once-weekly dosing 1 More ways to help your patients with T2D Check your patients' coverage and view savings offer Ozempic is available in 3 doses for more A1C control is available in 3 doses for more A1C control ARR=absolute risk reduction
Wegovy targets only GLP-1
Bergenstal RM, Strock ES, Peremislov D, Gibney MA, Parvu V, Hirsch LJ
Effective Dose: 2000 mg/day is associated with significant reductions in body weight, BMI, and fat mass